Sign inJoin waitlistJoin the waitlist

Joan Reibman

Supervisor · NYU Grossman School of Medicine

Credentials: · ·

History

NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Pulmonary Disease
Internal Medicine
Johns Hopkins University

Research

Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils
Journal of Clinical Investigation · 1995 · 291 citations
Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways
Proceedings of the National Academy of Sciences of the United States of America · 1991 · First of 8 authors · 210 citations
Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter
American Journal of Respiratory Cell and Molecular Biology · 2003 · First of 5 authors · Corresponding · 205 citations

Roberta Goldring
31 papers
KB
Kenneth Berger
30 papers
Linda Rogers
17 papers
William Rom
17 papers
Angeliki Kazeros
14 papers
Bob Wise
14 papers
BC
Bradley Chipps
11 papers
DB
David Beuther
11 papers
GW
Gerald Weissmann
11 papers
IG
Ileen Gilbert
11 papers
KH
Kathleen Haines
11 papers
KM
Kevin Murphy
11 papers

Grants

Cognitive Decline Among WTC Survivors with Chronic Mental and Physical Disorders
NIOSH · U01
PI · $2.4M · New York University School of Medicine
2022–2026
Complex WTC Exposures Impacting Persistent Large and Small Airflow Limitation and Vulnerable Subgroups in the WTC Survivor Population
NIOSH · U01
PI · $1.5M · New York University School of Medicine
2023–2026
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
NIOSH · U01
PI · $1.5M · New York University School of Medicine
2016–2019
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
NIOSH · U01
Contact PI · $2.7M · New York University School of Medicine
2013–2017

Clinical trials

Anxiety and COPD Evaluation
Principal investigator · Completed
NYU Langone Health
2016–2019
Sputum-derived Cellular Targets After Xolair (Omalizumab)
Principal investigator · Terminated · Phase 4
NYU Langone Health
2016–2018
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
Principal investigator · Completed
NYU Langone Health
2014–2017
NYU/Bellevue WTC Health Impacts Research Registry
Principal investigator · Recruiting
NYU Langone Health
2007–2027